Notice of Results
April 01 2008 - 2:00AM
UK Regulatory
Entelos Inc.
ENTELOS, INC.
NOTICE OF PRELIMINARY RESULTS FOR THE TWELVE MONTHS ENDED 31 DECEMBER 2007
Date: 16 April 2008
Entelos, Inc. (LSE: ENTL), a leading life sciences company building predictive
computer models and "virtual patients" for drug discovery and development,
announces that it will be releasing its preliminary results for the twelve
months ended 31 December 2007 on Wednesday 16 April 2008.
Analyst Briefing:
An Analyst briefing will be held at 10:00 am on 16 April at the offices of
Buchanan Communications, 45 Moorfields, London, EC2.
For further information please contact:
Entelos, Inc.
Jill Fujisaki, Vice President, Investor Tel: +1-650-572-5400
Relations
Buchanan Communications
Lisa Baderoon / Mary-Jane Johnson Tel +44-0-20-7466-5000
About Entelos
Entelos, Inc. (www.entelos.com) is a US-based life sciences company applying
next-generation predictive technologies to revolutionize the way medicines are
discovered, developed, and utilized. The Company leverages its proprietary in
silico disease models, "virtual patients", and toxicology reference systems to
develop safer and more effective drugs and support pharmaceutical R&D and
commercialization. In addition to internal drug programs in rheumatoid arthritis
and women's health, Entelos provides customized technology and research services
to global pharmaceutical and health-care companies in cardiovascular diseases,
asthma, obesity, diabetes, hematopoeisis (anemia), cholesterol metabolism, and
skin sensitization. The company is also developing a model in oncology and is
collaborating with the FDA to build a model of drug-induced liver injury.
Entelos offers cost-effective drug development capabilities through its
strategic alliance with India-based Jubilant Biosys.
Entelos Regs (LSE:ENTL)
Historical Stock Chart
From Jun 2024 to Jul 2024
Entelos Regs (LSE:ENTL)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about Entelos Regs (London Stock Exchange): 0 recent articles
More Entelos Inc. News Articles